Gregory T. Lucier, 40, is chairman and chief executive officer of Invitrogen Corp. (Nasdaq: IVGN), one of the world's leading biotechnology companies. Appointed in May 2003, Lucier is also chairman of the Invitrogen board of directors.
Invitrogen is a $1 billion life sciences company headquartered in Carlsbad. Conducting business in more than 70 countries, Invitrogen provides essential life technologies for disease research, drug discovery and commercial bioproduction.
The company's products and services are used in nearly every major laboratory worldwide, supporting academic and government research institutions as well as pharmaceutical and biotechnology corporations. Invitrogen employs more than 4,000 scientists and other professionals.
Prior to joining Invitrogen, Lucier served in a variety of executive positions at General Electric Co. (NYSE: GE), a global industrial and financial services concern. From 2000 to 2003, Lucier was president and CEO of GE's medical information technologies, which grew from a $700 million business into a $2 billion enterprise under his leadership.
From 1999 to 2000, he was vice president of global services for GE Medical Systems, a multibillion-dollar worldwide equipment services business.
In 1995, Lucier founded and served as president of GE Harris Railway Electronics, which he transformed from a startup company into a stand-alone GE affiliate with revenues in excess of $150 million by the end of 1999.
Lucier achieved a Master of Business Administration degree from Harvard University's Graduate School of Business Administration in 1990. An avid sports enthusiast, he was a member of the Harvard Business School Rugby Team. Lucier attained a Bachelor of Science degree in industrial engineering from Pennsylvania State University in 1986.
A native of Pennsylvania, Lucier and his wife, Marilena, have three children and reside in Olivenhain.